Clinical Trials Directory

Trials / Completed

CompletedNCT03792906

Comparison of Two Norepinephrine Bolus Doses for Management of Post-spinal Hypotension During Cesarean Delivery

Norepinephrine for Management of Post-spinal Anesthesia Hypotension During Cesarean Delivery: a Comparison of Two Bolus Doses

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
110 (actual)
Sponsor
Cairo University · Academic / Other
Sex
Female
Age
18 Years – 45 Years
Healthy volunteers
Not accepted

Summary

In this study the investigators will compare two doses of norepinephrine bolus (6 mcg and 10 mcg) in management of maternal hypotensive episode after subarachnoid block during Cesarean delivery.

Detailed description

Maternal hypotension after subarachnoid block is a frequent and deleterious complication during cesarean delivery. Although prophylaxis against hypotension using vasopressors had become a standard recommendation; the incidence of hypotension is still ∼ 20% . Thus; management of maternal hypotension using vasopressor boluses is usually needed . The commonly used vasopressors during cesarean delivery are ephedrine, phenylephrine, and recently norepinephrine. The use of ephedrine is usually accompanied with maternal tachycardia and fetal acidosis. Phenylephrine had been the first line for prevention and management of maternal hypotension; however, its use might result in bradycardia and decreased maternal cardiac output . Norepinephrine is an alpha adrenergic agonist with weak beta adrenergic agonistic activity; thus, it does not cause significant cardiac depression as phenylephrine does. Norepinephrine was introduced for use during cesarean delivery with promising results . Few previous studies investigated the efficacy of Norepinephrine infusion for prevention of maternal hypotension. A dose-response study had investigated the best dose of Norepinephrine for prevention of maternal hypotension. In the aforementioned dose-response study, a dose of 6 mcg was reported as the best dose for prophylaxis against maternal hypotension. No studies had investigated the best bolus dose of norepinephrine for management of a maternal hypotensive episode. In this study the investigators will investigate the efficacy and side effects of two doses of norepinephrine bolus doses (6 mcg and 10 mcg) in management of maternal hypotensive episode after subarachnoid block during cesarean delivery.

Conditions

Interventions

TypeNameDescription
DRUGNorepinephrine 6 mcgAn intravenous bolus of norepinephrine 6 mcg will be administered for management of maternal hypotension.
DRUGNorepinephrine 10 mcgAn intravenous bolus of norepinephrine 10 mcg will be administered for management of maternal hypotension.
DRUGNorepinephrine infusionProphylactic norepinephrine infusion will be started after subarachnoid block.
DRUGBupivacaine hydrochlorideSubarachnoid block will be performed using Bupivacaine hydrochloride (2.2 mL) in addition to fentanyl 25 mcg.

Timeline

Start date
2019-01-18
Primary completion
2019-04-25
Completion
2019-05-01
First posted
2019-01-04
Last updated
2021-09-24

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT03792906. Inclusion in this directory is not an endorsement.